Am. J. Respir. Cell Mol. Biol., Volume 22, Number 2, February, 2000 209-217

Cell Type-Specific Regulation of Fibrinogen Expression in Lung Epithelial Cells by Dexamethasone and Interleukin-1

Minh-Doan T. Nguyen and Patricia J. Simpson-Haidaris

Department of Microbiology and Immunology, Department of Medicine-Vascular Medicine Unit, and Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York

Our recent studies demonstrating the expression of fibrinogen (FBG) by an alveolar type II cell line stimulated with proinflammatory mediators and also in the inflamed pulmonary epithelium of animals with Pneumocystis carinii pneumonia suggest that extrahepatic FBG participates in the local acute phase response (APR) to infection and subsequent wound repair. However, the mechanisms that regulate extrahepatic FBG expression are poorly understood. This study compares the regulation of hepatic and pulmonary FBG expression by mediators of the APR, interleukin (IL)-6, IL-1, and dexamethasone (DEX), a synthetic glucocorticoid. Northern blotting and metabolic labeling studies revealed that IL-6 with or without DEX upregulates FBG messenger RNA and protein, whereas IL-1 inhibits FBG expression in human lung (A549) and liver (HepG2) epithelial cells. In contrast, the addition of DEX relieved the IL-1-mediated inhibition of FBG expression in lung epithelial cells only; this response is termed "DEX rescue." Studies with cycloheximide indicate that only DEX rescue required de novo protein synthesis. Nuclear run-on analysis revealed no increase in FBG transcription by DEX treatment. Although DEX treatment alone increased the stability of FBG transcripts in lung cells, this effect was not observed in the presence of IL-1. Together, these results suggest that pre-existing transcription factors mediate the effects of IL-6 with or without DEX, DEX, and IL-1 on FBG gene expression in lung and liver cells. Also, the data suggest that DEX induces new protein synthesis of an inhibitor of IL-1 signal transduction to effectively "rescue" FBG production in lung but not liver epithelial cells. This cell type-specific stimulation of FBG production by glucocorticoids to overcome IL-1 inhibition may promote pulmonary wound repair mechanisms.

This article has been cited by other articles:

				H. O. Duan and P. J. Simpson-Haidaris Cell Type-specific Differential Induction of the Human {gamma}-Fibrinogen Promoter by Interleukin-6 J. Biol. Chem., May 5, 2006; 281(18): 12451 - 12457. [Abstract] [Full Text] [PDF]

				B. J. Rybarczyk, S. O. Lawrence, and P. J. Simpson-Haidaris Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration Blood, December 1, 2003; 102(12): 4035 - 4043. [Abstract] [Full Text] [PDF]

				T. M. Odrljin, C. G. Haidaris, N. B. Lerner, and P. J. Simpson-Haidaris Integrin {alpha}v{beta}3-Mediated Endocytosis of Immobilized Fibrinogen by A549 Lung Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 12 - 21. [Abstract] [Full Text]